On Invalid Date, Cibus (NASDAQ: CBUS) reported Q3 2023 earnings per share (EPS) of -$1.59, up 75% year over year. Total Cibus earnings for the quarter were -$26.43 million. In the same quarter last year, Cibus's earnings per share (EPS) was -$6.36.
As of Q4 2023, Cibus's earnings has grown year over year. Cibus's earnings in the past year totalled -$53.35 million.
What was CBUS's revenue last quarter?
On Invalid Date, Cibus (NASDAQ: CBUS) reported Q3 2023 revenue of $475.00 thousand up 1,030.95% year over year. In the same quarter last year, Cibus's revenue was $42.00 thousand.
What was CBUS's revenue growth in the past year?
As of Q4 2023, Cibus's revenue has grown -63.27% year over year. This is 175.27 percentage points lower than the US Biotechnology industry revenue growth rate of 112.01%. Cibus's revenue in the past year totalled $756.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.